BRAND_ANALYSIS #SANOFI HEALTH & PHARMA #20 OF 26 IN HEALTH & PHARMA ALIGNED

Sanofi

· Private · Updated 04 Oct 2026 09:24 UTC
#814 of 1208 overall by tension · #20 of 26 in Health & Pharma
12 Aligned
The Balanced
Analysis

Big Pharma masquerading as culture (C=57) through corporate health theater. Sentiment=0.60 suggests people tolerate the brand; they don't love it.

IN THE NEWS (100 articles this week)
Sanofi, Regeneron expand tie-up with $8 billion drug-development deal, settle legal dispute - Reuters
Sanofi pays Dupixent partner Regeneron $1B upfront for 4 early-stage assets to ignite R&D - Fierce Biotech
Sanofi, Regeneron expand partnership after Dupixent success - STAT
Cultural Score
57 / 100
Business Score
69 / 100
TENSION▁▁▁▁▁▁▁▁▁▁▁▁▁▁
CULTURAL▄▄▄▄▄▄▄▄▄▄▄▄▄▄
BUSINESS▅▅▅▅▅▅▅▅▅▅▅▅▄▅
Loading...
Wikipedia Momentum 15/40
News Presence 43/35
Search InterestRedistributed to other dimensions
Stock Momentum 0/30
Market Position 0/25
Revenue Growth 0/25
Earnings Health 0/20
Sanofi's tension is 12. Commerce outpacing culture. sociologyofcapitalism.com/brand/sanofi
SHARE ON X
EMBED
<iframe src="https://sociologyofcapitalism.com/embed/sanofi.html" width="320" height="200" frameborder="0"></iframe>